Renal Insufficiency
240
15
19
156
Key Insights
Highlights
Success Rate
91% trial completion (above average)
Published Results
35 trials with published results (15%)
Research Maturity
156 completed trials (65% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
6.7%
16 terminated out of 240 trials
90.7%
+4.2% vs benchmark
19%
45 trials in Phase 3/4
22%
35 of 156 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 156 completed trials
Clinical Trials (240)
Registry of Pre-mixed Solutions in Critically Ill Patients on the Continuous Renal Replacement Therapy
Moderate-Intensity Statin Plus Ezetimibe in CKD and ASCVD
A Study to Test How Iclepertin is Taken up in the Blood of People With and Without Kidney Problems
Product Surveillance Registry
A Study of Pharmacokinetics and Safety of LY3537031 in Participants With Normal Renal Function and Participants With Renal Impairment
A Study of the Effect of a Nurse Navigator Program on High Risk Patients
Effects of SGLT2 Inhibitors on Erythropoiesis in Heart Failure
A Study of Eloralintide (LY3841136) in Participants With Renal Impairment and in Participants With Normal Renal Function
A Study of LY3537982 in Participants With Kidney Problems Compared With Participants With Normal Kidney Function
A One Visit Follow Up of Adults With Fabry Disease Who Started Long-term Enzyme Replacement Therapy As Children
SAVE-FistulaS: the SelfWrap-Assisted ArterioVEnous Fistulas Study
A Study of the Pharmacokinetics and Safety of Anaprazole Sodium in Special Populations
A Study to Determine Pharmacokinetic Changes of Ceftriaxone in Patients With Liver Cirrhosis
Food Frequency Questionnaire to Assess Sodium Intake
Safety, Tolerability and Pharmacokinetics of KBP-5074 in Healthy Subjects and Subjects With Renal Impairment
Concordance Between the Foot-to-Apex Systolic Interval and the Auscultatory Method for Measurement of Brachial Systolic Pressure in Patients With Severe Renal Failure
A Study to Test How BI 1015550 is Taken up in the Blood of People With and Without Kidney Problems
Comparison of HYDROLINK™ and HeprAN™ mEmbranes in a Per Dialytic Heparin Weaning Strategy in Chronic Hemodialysis Patients
Pharmacodynamic Comparison of Truncal Blocks in Patients With or Without Metabolic Disease (Kidney Failure, Diabetes)
A Study of Effect of Selpercatinib (LY3527723) in Participants With Normal and Impaired Renal Function